ANDA 86596, held by Sun Pharm Industries. Prednisone.
As of Nov 14, 2026, ANDA 86596 (Prednisone), held by Sun Pharm Industries, was first approved by FDA on Apr 10, 1979, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 10, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisone50MG · tablet;oral | Prednisone | Discontinued |
| Jun 5, 2024 | Supplement 24Labeling · Standard review | Approved | None posted |
| Dec 1, 1998 | Supplement 23Manufacturing | Approved | None posted |
| Apr 5, 1995 | Supplement 20Labeling | Approved | None posted |
| Dec 23, 1994 | Supplement 22Manufacturing | Approved | None posted |
| Oct 11, 1994 | Supplement 21Manufacturing | Approved | None posted |
| Apr 4, 1994 | Supplement 19Labeling | Approved | None posted |
| Apr 3, 1992 | Supplement 16Manufacturing | Approved | None posted |
| Apr 3, 1992 | Supplement 18Manufacturing | Approved | None posted |
| Mar 27, 1991 | Supplement 15Labeling | Approved | None posted |
| Apr 1, 1987 | Supplement 13Manufacturing | Approved | None posted |
| Mar 20, 1986 | Supplement 11Manufacturing | Approved | None posted |
| Apr 10, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters